# LATERA-OFFICE Study

> **NCT02964312** · NA · COMPLETED · sponsor: **Spirox, Inc.** · enrollment: 166 (actual)

## Conditions studied

- Nasal Obstruction

## Interventions

- **DEVICE:** Nasal Implant

## Key facts

- **NCT ID:** NCT02964312
- **Lead sponsor:** Spirox, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-10
- **Primary completion:** 2018-03-21
- **Final completion:** 2019-08-29
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2020-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02964312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02964312, "LATERA-OFFICE Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02964312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*